Skip to main content

Navigation group

Type at least 3 characters
709 articles

Articles

Original Research

Published on 12 Aug 2022

Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis

in Gastrointestinal Cancers: Colorectal Cancer

  • Alessandro Parisi
  • Riccardo Giampieri
  • Alex Mammarella
  • Cristiano Felicetti
  • Lisa Salvatore
  • Maria Bensi
  • Maria Grazia Maratta
  • Antonia Strippoli
  • Roberto Filippi
  • Maria Antonietta Satolli
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.935826
  • 3,464 views